Share-based Payment Arrangement, Expense of Silexion Therapeutics Corp from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Silexion Therapeutics Corp quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • Silexion Therapeutics Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $38,000, a 99% decline year-over-year.
  • Silexion Therapeutics Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $96,000.
  • Silexion Therapeutics Corp annual Share-based Payment Arrangement, Expense for 2024 was $5,862,000, a 4409% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Silexion Therapeutics Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $96,000 $38,000 -$5,760,000 -99% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $5,856,000 $37,000 +$5,000 +16% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $5,851,000 $21,000 -$11,000 -34% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $5,862,000 $0 01 Oct 2024 31 Dec 2024 8-K 20 Aug 2025
Q3 2024 $5,798,000 +$5,766,000 +18019% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $32,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $32,000 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q3 2023 $32,000 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $32,000 01 Apr 2023 30 Jun 2023 10-Q 29 Aug 2024 2024 Q2

Silexion Therapeutics Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $5,862,000 +$5,732,000 +4409% 01 Jan 2024 31 Dec 2024 8-K 20 Aug 2025
2023 $130,000 01 Jan 2023 31 Dec 2023 8-K 20 Aug 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.